AmerisourceBergen Pays $625M To Resolve Drug Repackaging False Claims Allegations
BROOKLYN, N.Y. — Drug wholesaler AmerisourceBergen Corp. and four subsidiaries have agreed to pay $625 million to resolve civil allegations that they improperly repackaged cancer drugs into prefilled syringes, resulting in...To view the full article, register now.
Already a subscriber? Click here to view full article